Disruption of human plasma cell differentiation by an environmental polycyclic aromatic hydrocarbon: A mechanistic immunotoxicological study

Environmental Health: A Global Access Science Source

Volumn 9, Issue 1, 2010, Pages

  Allan, Lenka L ^a,b   Sherr, David H ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CD40 LIGAND; POLYCYCLIC AROMATIC HYDROCARBON;

CELL ORGANELLE; IMMUNITY; IMMUNOASSAY; INHIBITION; IRRADIATION; LIGAND; PAH; PYRENE; TOXICOLOGY;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOTOXICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; GENETICS; IMMUNOLOGY; POLLUTANT;

CD40 LIGAND; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; HUMANS; PLASMA CELLS; POLYCYCLIC HYDROCARBONS, AROMATIC;

EID: 77950831086     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-9-15     Document Type: Article

References (63)

1. CYP1A1 in polycyclic aromatic hydrocarbon-induced B lymphocyte growth suppression. LL Allan, JJ Schlezinger, M Shansab, DH Sherr, Biochem Biophys Res Commun 2006 342 227 235 10.1016/j.bbrc.2006.01.131 16472762 (Pubitemid 43247381)
2. Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. K Yamaguchi, RI Near, RA Matulka, A Shneider, P Toselli, AF Trombino, DH Sherr, J Immunol 1997 158 2165 2173 9036962 (Pubitemid 127469999)
3. DMBA induces programmed cell death (apoptosis) in the A20.1 murine B cell lymphoma. SW Burchiel, DA Davis, SD Ray, SL Barton, Fundam Appl Toxicol 1993 21 120 124 10.1006/faat.1993.1080 8365579 (Pubitemid 23225993)
4. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p- dioxin. JS Fine, AE Silverstone, TA Gasiewicz, J Immunol 1990 144 1169 1176 2303704 (Pubitemid 20072879)
5. Differential effects of diethylstilbestrol and 2,3,7,8- tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. ZW Lai, NC Fiore, PJ Hahn, TA Gasiewicz, AE Silverstone, Toxicol Appl Pharmacol 2000 168 15 24 10.1006/taap.2000.9015 11000096
6. Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity. DM Shepherd, LB Steppan, OR Hedstrom, NI Kerkvliet, Toxicol Appl Pharmacol 2001 170 10 22 10.1006/taap.2000.9080 11141351 (Pubitemid 32066382)
7. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a] anthracene (DMBA) in vitro. LM Thurmond, RV House, LD Lauer, JH Dean, Toxicol Appl Pharmacol 1988 93 369 377 10.1016/0041-008X(88)90039-7 2835829
8. Quantitative and functional change in T cells of primiparous mice following injection of benzo(a)pyrene at the second trimester of pregnancy. P Urso, RA Johnson, Immunopharmacol Immunotoxicol 1988 10 195 217 10.3109/08923978809014333 2971711
9. Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. K Yamaguchi, RA Matulka, AM Shneider, P Toselli, AF Trombino, S Yang, LJ Hafer, KK Mann, XJ Tao, JL Tilly, et al. Toxicol Appl Pharmacol 1997 147 190 203 10.1006/taap.1997.8263 9439715 (Pubitemid 28062737)
10. Flow cytometric analysis of lymphocyte subpopulations in the spleen and thymus of mice exposed to an acute immunosuppressive dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). NI Kerkvliet, JA Brauner, Environ Res 1990 52 146 154 10.1016/S0013-9351(05)80249-X 2118453 (Pubitemid 20313143)
11. Thymic stroma exposed to arylhydrocarbon receptor-binding xenobiotics fails to support proliferation of early thymocytes but induces differentiation. J Kremer, E Gleichmann, C Esser, J Immunol 1994 153 2778 2786 8077682 (Pubitemid 24278147)
12. Alternate immune system targets for TCDD: lymphocyte stem cells and extrathymic T-cell development. AE Silverstone, DE Frazier Jr, TA Gasiewicz, Exp Clin Immunogenet 1994 11 94 101 7826670 (Pubitemid 24305629)
13. Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. WH De Jong, ED Kroese, JG Vos, H Van Loveren, Toxicol Sci 1999 50 214 220 10.1093/toxsci/50.2.214 10478857 (Pubitemid 29407083)
14. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance. EC Ward, MJ Murray, LD Lauer, RV House, R Irons, JH Dean, Toxicol Appl Pharmacol 1984 75 299 308 10.1016/0041-008X(84)90212-6 6433512 (Pubitemid 14026441)
15. Alterations in murine fetal thymus and liver hematopoietic cell populations following developmental exposure to 7,12-dimethylbenz[a]anthracene. SD Holladay, BJ Smith, Environ Res 1995 68 106 113 10.1006/enrs.1995.1014 7601071
16. Immunosuppression by polycyclic aromatic hydrocarbons: a structure-activity relationship in B6C3F1 and DBA/2 mice. KL White Jr, HH Lysy, MP Holsapple, Immunopharmacology 1985 9 155 164 10.1016/0162-3109(85)90011-6 4040508 (Pubitemid 15003616)
17. Suppression of humoral and cell-mediated immune responses in vitro by benzo(a)pyrene. P Urso, N Gengozian, RM Rossi, RA Johnson, J Immunopharmacol 1986 8 223 241 10.3109/08923978609028616 2941486 (Pubitemid 16068596)
18. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice - II. Altered cell-mediated immunity and tumor resistance. JH Dean, EC Ward, MJ Murray, LD Lauer, RV House, W Stillman, TA Hamilton, DO Adams, Int J Immunopharmacol 1986 8 189 198 10.1016/0192-0561(86)90058-5 3086244 (Pubitemid 16142924)
19. Activation of the aryl hydrocarbon receptor diminishes the memory response to homotypic influenza virus infection but does not impair host resistance. BP Lawrence, BA Vorderstrasse, Toxicol Sci 2004 79 304 314 10.1093/toxsci/kfh094 14976337 (Pubitemid 38786888)
20. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. B Martin, K Hirota, DJ Cua, B Stockinger, M Veldhoen, Immunity 2009 31 321 330 10.1016/j.immuni.2009. 06.020 19682928
21. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. M Veldhoen, K Hirota, J Christensen, A O'Garra, B Stockinger, J Exp Med 2009 206 43 49 10.1084/jem.20081438 19114668
22. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. M Veldhoen, K Hirota, AM Westendorf, J Buer, L Dumoutier, JC Renauld, B Stockinger, Nature 2008 453 106 109 10.1038/nature06881 18362914 (Pubitemid 351630329)
23. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. FJ Quintana, AS Basso, AH Iglesias, T Korn, MF Farez, E Bettelli, M Caccamo, M Oukka, HL Weiner, Nature 2008 453 65 71 10.1038/nature06880 18362915 (Pubitemid 351630328)
24. Environmental control of Th17 differentiation. FJ Quintana, HL Weiner, Eur J Immunol 2009 39 655 657 10.1002/eji.200839198 19283716
25. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. NI Kerkvliet, DM Shepherd, L Baecher-Steppan, Toxicol Appl Pharmacol 2002 185 146 152 10.1006/taap.2002.9537 12490139 (Pubitemid 36062805)
26. Functional characterization and gene expression analysis of CD4+ CD25+ regulatory T cells generated in mice treated with 2,3,7,8-tetrachlorodibenzo-p- dioxin. NB Marshall, WR Vorachek, LB Steppan, DV Mourich, NI Kerkvliet, J Immunol 2008 181 2382 2391 18684927
27. Direct effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human tonsillar lymphocytes. SC Wood, HG Jeong, DL Morris, MP Holsapple, Toxicology 1993 81 131 143 10.1016/0300-483X(93)90005-D 8378939 (Pubitemid 223051376)
28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells. RB Crawford, CE Sulentic, BS Yoo, NE Kaminski, Toxicol Sci 2003 75 333 342 10.1093/toxsci/kfg199 12883080 (Pubitemid 37220281)
29. Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. LL Allan, DH Sherr, Mol Pharmacol 2005 67 1740 1750 10.1124/mol.104.009100 15681594 (Pubitemid 40594175)
30. Bone Marrow Stromal-B Cell Interactions in Polycyclic Aromatic Hydrocarbon-Induced Pro/Pre-B Cell Apoptosis. LL Allan, KK Mann, RA Matulka, HY Ryu, JJ Schlezinger, DH Sherr, Toxicol Sci 2003 76 357 365 10.1093/toxsci/kfg239 14514961 (Pubitemid 38035428)
31. Environmental chemical-induced bone marrow B cell apoptosis: death receptor-independent activation of a caspase-3 to caspase-8 pathway. HY Ryu, JK Emberley, JJ Schlezinger, LL Allan, S Na, DH Sherr, Mol Pharmacol 2005 68 1087 1096 10.1124/mol.105.014712 16014577 (Pubitemid 41345800)
32. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. K Tarte, J De Vos, T Thykjaer, F Zhan, G Fiol, V Costes, T Reme, E Legouffe, JF Rossi, J Shaughnessy Jr, et al. Blood 2002 100 1113 1122 12149187 (Pubitemid 34864260)
33. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. G Jego, AK Palucka, JP Blanck, C Chalouni, V Pascual, J Banchereau, Immunity 2003 19 225 234 10.1016/S1074-7613(03)00208-5 12932356 (Pubitemid 37011337)
34. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. DF Jelinek, PE Lipsky, J Immunol 1983 130 2597 2604 6189896 (Pubitemid 13107677)
35. Isotype switching by human B cells is division-associated and regulated by cytokines. SG Tangye, A Ferguson, DT Avery, CS Ma, PD Hodgkin, J Immunol 2002 169 4298 4306 12370361 (Pubitemid 35178202)
36. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. SG Tangye, DT Avery, PD Hodgkin, J Immunol 2003 170 261 269 12496408 (Pubitemid 36026148)
37. Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. SG Tangye, DT Avery, EK Deenick, PD Hodgkin, J Immunol 2003 170 686 694 12517929 (Pubitemid 36070517)
38. Divide and conquer: the importance of cell division in regulating B-cell responses. SG Tangye, PD Hodgkin, Immunology 2004 112 509 520 10.1111/j.1365-2567.2004.01950.x 15270721 (Pubitemid 39061475)
39. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. BP O'Connor, M Cascalho, RJ Noelle, J Exp Med 2002 195 737 745 10.1084/jem.20011626 11901199 (Pubitemid 34259718)
40. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. K Agematsu, H Nagumo, Y Oguchi, T Nakazawa, K Fukushima, K Yasui, S Ito, T Kobata, C Morimoto, A Komiyama, Blood 1998 91 173 180 9414282 (Pubitemid 28018742)
41. Generation of memory B cells and plasma cells in vitro. C Arpin, J Dechanet, C Van Kooten, P Merville, G Grouard, F Briere, J Banchereau, YJ Liu, Science 1995 268 720 722 10.1126/science.7537388 7537388
42. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. G Jego, R Bataille, C Pellat-Deceunynck, Blood 2001 97 1817 1822 10.1182/blood.V97.6.1817 11238125 (Pubitemid 32217251)
43. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. A Silvy, C Lagresle, C Bella, T Defrance, Eur J Immunol 1996 26 517 524 10.1002/eji.1830260303 8605915 (Pubitemid 26091377)
44. Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not by the noncarcinogenic congener benzo(e)pyrene. KL White Jr, MP Holsapple, Cancer Res 1984 44 3388 3393 6331644 (Pubitemid 14098587)
45. Persistent suppression of humoral and cell-mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a] anthracene. EC Ward, MJ Murray, LD Lauer, RV House, JH Dean, Int J Immunopharmacol 1986 8 13 22 10.1016/0192-0561(86)90068-8 3082776 (Pubitemid 16170391)
46. Persistent suppression of humoral immunity produced by 7,12-dimethylbenz(A)anthracene (DMBA) in B6C3F1 mice: correlation with changes in spleen cell surface markers detected by flow cytometry. SW Burchiel, WM Hadley, SL Barton, RH Fincher, LD Lauer, JH Dean, Int J Immunopharmacol 1988 10 369 376 10.1016/0192-0561(88)90123-3 3139575
47. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. CE Sulentic, MP Holsapple, NE Kaminski, Mol Pharmacol 1998 53 623 629 9547351 (Pubitemid 28196483)
48. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. CE Sulentic, MP Holsapple, NE Kaminski, J Pharmacol Exp Ther 2000 295 705 716 11046109
49. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. KI Lin, C Angelin-Duclos, TC Kuo, K Calame, Mol Cell Biol 2002 22 4771 4780 10.1128/MCB.22.13.4771-4780.2002 12052884 (Pubitemid 34620412)
50. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. BS Yoo, DR Boverhof, D Shnaider, RB Crawford, TR Zacharewski, NE Kaminski, Toxicol Sci 2004 77 272 279 10.1093/toxsci/kfh013 14600275 (Pubitemid 38262600)
51. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. T Czerny, G Schaffner, M Busslinger, Genes Dev 1993 7 2048 2061 10.1101/gad.7.10.2048 8406007 (Pubitemid 23312955)
52. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BSAP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes. SA Masten, KT Shiverick, Biochem Biophys Res Commun 1995 212 27 34 10.1006/bbrc.1995.1931 7541987
53. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. R Schreck, P Rieber, PA Baeuerle, Embo J 1991 10 2247 2258 2065663 (Pubitemid 21905698)
54. Antioxidant and redox regulation of gene transcription. CK Sen, L Packer, Faseb J 1996 10 709 720 8635688 (Pubitemid 26172817)
55. Involvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation. CK Sen, S Roy, L Packer, FEBS Lett 1996 385 58 62 10.1016/0014-5793(96)00346-8 8641467
56. CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism. S Merluzzi, M Moretti, S Altamura, P Zwollo, M Sigvardsson, G Vitale, C Pucillo, J Biol Chem 2004 279 1777 1786 10.1074/jbc.M305418200 14594818 (Pubitemid 38084445)
57. Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. C Gaiddon, NC Moorthy, C Prives, Embo J 1999 18 5609 5621 10.1093/emboj/18.20.5609 10523305 (Pubitemid 29486380)
58. An 'environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation. G Tell, A Zecca, L Pellizzari, P Spessotto, A Colombatti, MR Kelley, G Damante, C Pucillo, Nucleic Acids Res 2000 28 1099 1105 10.1093/nar/28.5.1099 10666449 (Pubitemid 30107677)
59. An exonucleolytic activity of human apurinic/apyrimidinic endonuclease on 3' mispaired DNA. KM Chou, YC Cheng, Nature 2002 415 655 659 10.1038/415655a 11832948 (Pubitemid 34136394)
60. Redox regulation of cellular activation. H Nakamura, K Nakamura, J Yodoi, Annu Rev Immunol 1997 15 351 369 10.1146/annurev.immunol.15.1.351 9143692 (Pubitemid 27169285)
61. Ref-1 controls pax-8 DNA-binding activity. G Tell, L Pellizzari, D Cimarosti, C Pucillo, G Damante, Biochem Biophys Res Commun 1998 252 178 183 10.1006/bbrc.1998.9548 9813166 (Pubitemid 28534647)
62. Redox potential controls the structure and DNA binding activity of the paired domain. G Tell, A Scaloni, L Pellizzari, S Formisano, C Pucillo, G Damante, J Biol Chem 1998 273 25062 25072 10.1074/jbc.273.39.25062 9737963 (Pubitemid 28443263)
63. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. C Heilmann, P Grandjean, P Weihe, F Nielsen, E Budtz-Jorgensen, PLoS Med 2006 3 311 10.1371/journal.pmed.0030311 16942395 (Pubitemid 44338373)